ICTA

keyboard_backspaceBack to Home

Contact

location_on

11, rue du Bocage
21121 FONTAINE LES DIJON
France

public

https://www.icta.fr

Remi GAUCHOUX
Directeur des opérations commerciales
mail

remi.gauchoux@icta.fr

call

+33 (0) 625 875 073

About us

ICTA is an international full-service CRO offering pharmaceutical and medical device professionals an end-to-end service for their product development in Europe and North America.

From early development to post-approval, we provide expert guidance to improve and accelerate the development of your product, and support you across its entire life cycle.

Business offer

ICTA's services cover all phases of clinical development:


- interventional clinical studies from phase I to IV,
- non-interventional studies / RWE studies
- early access and compassionate programs (EAP / CUP)


in a wide range of therapeutic areas, whether the product under investigation is a chemical, biological, medical device, ATMP, or diagnostic.

 

Our services are offered on a full-service or "à la carte" basis and include :

  • - R&D Consulting, Development plan, Design of study protocols and synopsis
  • - Selection of countries, Key Opinion Leaders and participating centers
  • - Aid to decision making
  • - Feasibility studies
  • - Management of investigational networks
  • - Management of regulatory affairs
  • - Management of contracts and fees
  • - Management of study logistics
  • - Development of integrated secure IT tools (e-CRFs, e-PROs, IWRS)
  • - On-site, remote and centralized monitoring
  • - Pharmacovigilance / Materiovigilance
  • - Data management
  • - Traditional and advanced biostatistics, modelling (Data mining, - - Bayesian network, neural analysis)
  • - Medical writing (clinical report, abstracts, publications)

Activities

    Categories

    • Service

    Therapeutic applications

    • Cardiology
    • Genetic Diseases
    • Oncology
    • Nervous Central System
    • Hematology
    • Infectiology
    • Immunology
    • Ophthalmology
    • Inflammation
    • Other

    Expertises

    Directory of Antibodies, Recombinant proteins and others
    • Clinical trials
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Regulatory filing
    • Regulatory Filing
    Cell Therapy Directory
    Gene and CAR-T cell therapy Directory
    Prophylactic Vaccines Directory
    • Clinical trials
    • Phase I
    • Phase II (human challenge trials)
    • Phase III (large population pending pathogen prevalence)
    • Data management
    • Post-market surveillance
    • Clinical Trial phase IV
Français English